Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
about
Cancer stem cell metabolismRestoration of mitochondria function as a target for cancer therapyThe calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells.Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.Global variability in gene expression and alternative splicing is modulated by mitochondrial content.Mitochondrial retrograde signaling regulates neuronal functionRAP80 regulates epithelial-mesenchymal transition related with metastasis and malignancy of cancer.Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer.Mitochondrial-epigenetic crosstalk in environmental toxicology.TUFM downregulation induces epithelial-mesenchymal transition and invasion in lung cancer cells via a mechanism involving AMPK-GSK3β signaling.Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance.Disruption of cytochrome c oxidase function induces the Warburg effect and metabolic reprogramming.Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression.Mining long noncoding RNA in livestock.Spotlight on the relevance of mtDNA in cancer.Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.HnRNPA2 is a novel histone acetyltransferase that mediates mitochondrial stress-induced nuclear gene expression.Non-coding RNAs: the dark side of nuclear-mitochondrial communication.Mitochondrial determinants of cancer health disparities.Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.Mitochondrial dysfunction and potential anticancer therapy.Mitochondrial stress-induced p53 attenuates HIF-1α activity by physical association and enhanced ubiquitination.Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.More challenges ahead-metabolic heterogeneity of pancreatic cancer stem cells.Transcriptomic analysis of mitochondrial TFAM depletion changing cell morphology and proliferation.Global mapping of transcription factor motifs in human aging.Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression.Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer.Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
P2860
Q26746123-9F77BF18-C349-4A97-81F3-FD3943AE2EDFQ26864167-FBE34383-54B3-4B3A-9F8D-F9058925534EQ27330253-8D6970F5-1735-4ED1-B7A9-0F4BD1DDB81EQ34555855-739C2E47-160F-40FD-B193-300813EBD97BQ35561948-AEB2D3E9-877E-44DB-8942-C8D55DC08DCFQ36268449-D5179480-A061-4942-AD78-577107EB3E5AQ36746310-6A0E9F04-3B32-46DA-A7DE-3C6643739F7CQ37050481-F419EA02-9F1B-49B2-B1CF-03CDBE2B8AD4Q38255668-1F64124F-1466-4DAE-80C4-C857D1CF7CDBQ38311505-9A1E445C-7046-4C75-9A32-6CE0A2075689Q38635442-B54B6EA5-D57F-4955-A184-8D233EE1C461Q38802165-323E7909-940A-4815-A697-DAABF7B7BD94Q38834623-4527A565-502A-43E3-ADE9-EDABEF8A9ED8Q38856267-A354A524-C73B-47CE-803C-ADC20C879D9AQ38912201-42E1C8FD-A257-4CD2-BC45-973126B4E3E9Q38951218-583C241B-7F96-41F6-A776-FB3CCEF29EA2Q38990083-19710E19-4C46-412B-A3D8-06A398C5D591Q39011563-57D76E0A-2CD9-43F8-BAE0-CB3FA89F9AE5Q39090246-D940BC1A-6D0D-4698-8918-C168E9A43D73Q39185393-6CA3D3DA-E87A-4FCE-861D-32E709533ABEQ39294200-EAE4B39D-720C-4F3A-BC87-A60AEDD130F4Q39305244-4E95CF16-B1FB-4CED-B1B0-9B898FFF1EB3Q39418003-7CBA9A56-1CB6-404D-B8BB-5F87EB728BA2Q40030805-72DEFD44-DEB7-4CB8-807F-ECE0BFC83FB9Q41260173-A085A3A3-508B-441A-9F9B-2624E19A2BD8Q42729808-0ED3F17F-685E-4231-83EE-30934D87FEB1Q47167974-33B28F1C-2CBB-4C68-9B42-65860DECB32DQ47205354-69962E5A-A811-49B5-85B1-4DF98BA31CDDQ48158195-FD560918-FF8C-477C-AA32-BFA80A5F6881Q49708541-7F5C5422-C33D-4530-A867-8BC48645465CQ49978837-E4D0C0BF-DAC1-437D-B50B-02FEE8952788Q55254924-5CA16C9E-E546-4AD3-87E8-36A7106244EC
P2860
Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@en
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@nl
type
label
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@en
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@nl
prefLabel
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@en
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Mitochondrial retrograde signa ...... ates breast cancer stem cells.
@en
P2093
A K Kashina
N G Avadhani
R P Carstens
S Srinivasan
T Van Winkle
P2860
P2888
P304
P356
10.1038/ONC.2013.467
P407
P577
2013-11-04T00:00:00Z
P5875
P6179
1003412020